Development and validation of SCOPE score: A clinical score to predict COVID-19 pneumonia progression to severe respiratory failure

Most patients infected with SARS-CoV-2 (COVID-19) experience mild, non-specific symptoms, but many develop severe symptoms associated with an excessive inflammatory response. Elevated plasma concentrations of soluble urokinase plasminogen activator receptor (suPAR) provide early warning of progressi...

Descripción completa

Detalles Bibliográficos
Autores principales: Giamarellos-Bourboulis, Evangelos J., Poulakou, Garyfallia, de Nooijer, Aline, Milionis, Haralampos, Metallidis, Simeon, Ploumidis, Michalis, Grigoropoulou, Pinelopi, Rapti, Aggeliki, Segala, Francesco Vladimiro, Balis, Evangelos, Giannitsioti, Efthymia, Rodari, Paola, Kainis, Ilias, Alexiou, Zoi, Focà, Emanuele, Lucio, Brollo, Rovina, Nikoletta, Scorzolini, Laura, Dafni, Maria, Ioannou, Sofia, Tomelleri, Alessandro, Dimakou, Katerina, Tzatzagou, Glykeria, Chini, Maria, Bassetti, Matteo, Trakatelli, Christina, Tsoukalas, George, Selmi, Carlo, Samaras, Charilaos, Saridaki, Maria, Pyrpasopoulou, Athina, Kaldara, Elisabeth, Papanikolaou, Ilias, Argyraki, Aikaterini, Akinosoglou, Karolina, Koupetori, Marina, Panagopoulos, Periklis, Dalekos, George N., Netea, Mihai G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8872836/
https://www.ncbi.nlm.nih.gov/pubmed/35474750
http://dx.doi.org/10.1016/j.xcrm.2022.100560

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8872836/
https://www.ncbi.nlm.nih.gov/pubmed/35474750
http://dx.doi.org/10.1016/j.xcrm.2022.100560

Ejemplares similares